Who owns Rigel Pharmaceuticals?

Key details on Rigel Pharmaceuticals (Ticker: RIGL)

Who owns Rigel Pharmaceuticals?

Is RIGL a good stock to own? Find out who bought Rigel Pharmaceuticals, who sold Rigel Pharmaceuticals (RIGL) stock, and who holds a large position in Rigel Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 13.21M $47.15M March 31, 2015
Broadfin Capital 8.50M $19.30M Dec. 31, 2014
Palo Alto Investors 5.18M $18.48M March 31, 2015
OppenheimerFunds 5.00M $17.85M March 31, 2015
Wellington Management Company 4.92M $17.58M March 31, 2015
T. Rowe Price Associates 4.61M $16.51M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 3.27M $11.67M March 31, 2015
NEA Management Company 3.24M $11.58M March 31, 2015
Vanguard 3.08M $10.98M March 31, 2015
Millennium Management 3.06M $5.93M Sept. 30, 2014
BVF 2.58M $10.00M March 31, 2014
Deerfield Management Company 2.40M $8.56M March 31, 2015
BlackRock Fund Advisors 2.37M $8.47M March 31, 2015
STATE STREET CORPORATION 2.27M $14.74M Dec. 31, 2013
SENZAR ASSET MANAGEMENT 2.12M $4.81M Dec. 31, 2014
D. E. Shaw & Co 2.08M $7.41M March 31, 2015
Visium Asset Management 2.01M $5.73M Dec. 31, 2013